Severin Schwan thinks the skeptics are wrong. Those who shun the pharmaceutical sector for its lack of prospects don't understand the potential created by a rapidly growing understanding of genetics and molecular biology, and the new drugs that will follow. "There are people who would argue that all the low-hanging fruits have been harvested and that the pharmaceutical industry is at an end," Mr. Schwan says.
